Seeley v. State

940 P.2d 604
CourtWashington Supreme Court
DecidedJuly 24, 1997
Docket63534-0
StatusPublished

This text of 940 P.2d 604 (Seeley v. State) is published on Counsel Stack Legal Research, covering Washington Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Seeley v. State, 940 P.2d 604 (Wash. 1997).

Opinion

940 P.2d 604 (1997)
132 Wash.2d 776

Ralph SEELEY, Respondent,
v.
STATE of Washington, Appellant.

No. 63534-0.

Supreme Court of Washington, En Banc.

Argued September 25, 1996.
Decided July 24, 1997.

*606 Christine Gregoire, Attorney General, Melissa Cain, Assistant Attorney General, Olympia, for Appellant.

Ralph Seeley, Tacoma, for Respondent.

Kevin Hamilton, Erika J. Starrs, Stephen C. Willey, Seattle, Jeffrey T. Haley, Bellevue, Davis, Wright & Tremaine, Bruce Johnson, Gregory Kopta, Kraig Baker, Steinborn & Associates, Jeffrey Steinborn, Seattle, Michael Cutler, Boston, MA, for Amicus Curiae.

*605 MADSEN, Justice.

The State appeals a decision of the Pierce County Superior Court holding that RCW 69.50.204(c)(14), which places marijuana in Schedule I of controlled substances, is unconstitutional, violating art. I, §§ 12, and 32 of the Washington Constitution. This court concludes that RCW 69.50.204(c)(14) does not violate the Washington Constitution and reverses the trial court.

STATEMENT OF THE CASE

The Respondent, Mr. Seeley, was diagnosed with chordoma, a rare form of bone cancer, in 1986. Mr. Seeley has undergone numerous surgeries including the removal of his right lung and a removal of part of the lower lobe of his left lung. Mr. Seeley also suffers from "severe Obstructive Airway Disease." *607 Clerk's Papers (CP) at 267. Mr. Seeley's condition is diagnosed as terminal.

Throughout his battle with cancer, Mr. Seeley has received radiation therapy and chemotherapy. Mr. Seeley was treated with various chemotherapeutic agents which commonly produce nausea and vomiting. He was treated with synthetic tetrahydrocannabinal (THC) (Marinol or dronabinol) and other antiemetic drugs for the nausea and vomiting which resulted from the chemotherapy. Mr. Seeley has also smoked marijuana during chemotherapy. Mr. Seeley prefers smoking marijuana to control these side effects. Mr. Seeley states that smoking marijuana has been more effective in relieving his symptoms than other antiemetics.

Marijuana is a hallucinogen derived from the Indian hemp plant. One of the principle active ingredients in marijuana is delta-9-tetrahydrocannabinal (THC). The amount of THC present in marijuana varies in the plant depending on the origin of the plant, growing conditions, and cultivation. In addition to THC, marijuana contains over 400 other chemical substances including 61 identified cannabinoids, the active ingredients in marijuana, including THC. In 1986, the pure synthetic form of THC (Marinol or dronabinol) was approved by the federal Food and Drug Administration (FDA) and is used as an antiemetic. The FDA has not approved marijuana for medical treatment.

Marijuana is regulated by both the state and federal government. Washington adopted the Uniform Controlled Substances Act, RCW 69.50, in 1971. The Uniform Controlled Substances Act parallels the federal Comprehensive Drug Abuse Prevention and Control Act of 1970, 21 U.S.C. § 801 (1996 Supp.). These laws establish a comprehensive statutory mechanism to control the manufacture, distribution, and use of controlled substances. Penalties are imposed for violations of the law. Both statutes place controlled substances in numerical schedules I to V and create an administrative mechanism to change the placement of substances on the various schedules. Substances on schedule I are illegal under all circumstances except for research. Substances on schedules II to V are legal to possess only under a valid prescription. Federal and state laws impose tandem registration requirements on practitioners, pharmacists and manufacturers of controlled substances.

Both federal and state statutes list marijuana in schedule I of controlled substances. See RCW 69.50.204(c)(14); 21 C.F.R. § 1308.11(d)(19) (1996). Thus, it is illegal for use under all circumstances except under narrow exceptions for research. Controlled substances listed in schedule I under federal law may not be prescribed or dispensed anywhere in the United States unless a specific registration to do so is obtained to use the substance for research purposes. See 21 U.S.C. §§ 822-23, 872 (1981). Marijuana cannot be legally prescribed, nor can a prescription for marijuana be filled by a pharmacist in Washington unless a federal registration is granted.

The State of Washington obtained federal approval to use marijuana for research purposes and the Legislature passed the Controlled Substances Therapeutic Research Act (Research Act) in 1979. RCW 69.51. The Research Act was enacted to determine if the principle ingredient in marijuana, THC, was effective in the treatment of nausea and vomiting caused by radiation and chemotherapy. RCW 69.51.020; see also CP at 41. Although still law, the Legislature stopped funding the program in 1980. The reason given for the discontinuation of funding was because the results were favorable and THC was synthesized, approved by the FDA, and marketed as Marinol. Thus, the Legislature determined that state funding was no longer necessary.

However, in 1996, the Washington Legislature restored funding to the board of pharmacy to study the effects of medicinal marijuana.[1] The study is to be performed in connection with a Washington State University research project which will research a tamper-free means of cultivating effective and safe marijuana plants for medicinal purposes. *608 1996 Legislative Budget Notes, Supplemental Budget, § 217, at 114 n. 8, § 605, at 169 n. 8.[2]

Similar to the federal statute, Washington's Uniform Controlled Substances Act classifies controlled substances based on their therapeutic value, potential for abuse, and safety. A substance is listed in schedule I if it has (1) a high potential for abuse, (2) no currently accepted medical use in treatment in the United States, and (3) no accepted safety for use in treatment under medical supervision. RCW 69.50.201. A substance is placed in schedule II upon finding that: (1) the substance has a high potential for abuse, (2) the substance has currently accepted medical use in treatment or currently accepted medical use with severe restrictions, and (3) the abuse of the substance may lead to severe psychic or physical dependence. RCW 69.50.205.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hurtado v. California
110 U.S. 516 (Supreme Court, 1884)
Lawton v. Steele
152 U.S. 133 (Supreme Court, 1894)
Whitney v. California
274 U.S. 357 (Supreme Court, 1927)
Williamson v. Lee Optical of Oklahoma, Inc.
348 U.S. 483 (Supreme Court, 1955)
Poe v. Ullman
367 U.S. 497 (Supreme Court, 1961)
Goldblatt v. Town of Hempstead
369 U.S. 590 (Supreme Court, 1962)
Schneider v. Smith
390 U.S. 17 (Supreme Court, 1968)
Leary v. United States
395 U.S. 6 (Supreme Court, 1969)
Roe v. Wade
410 U.S. 113 (Supreme Court, 1973)
Buckley v. Valeo
424 U.S. 1 (Supreme Court, 1976)
Mathews v. De Castro
429 U.S. 181 (Supreme Court, 1976)
New York City Transit Authority v. Beazer
440 U.S. 568 (Supreme Court, 1979)
United States v. Rutherford
442 U.S. 544 (Supreme Court, 1979)
Youngberg v. Romeo Ex Rel. Romeo
457 U.S. 307 (Supreme Court, 1982)
Daniels v. Williams
474 U.S. 327 (Supreme Court, 1986)
Bowers v. Hardwick
478 U.S. 186 (Supreme Court, 1986)
Foucha v. Louisiana
504 U.S. 71 (Supreme Court, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
940 P.2d 604, Counsel Stack Legal Research, https://law.counselstack.com/opinion/seeley-v-state-wash-1997.